title: [Prevalence and factors associated with HIV and viral hepatitis B and C in the city of Bafoussam in Cameroon].
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon ; Department of Laboratories and Blood Safety, Ministry of Public Health, Yaoundé, Cameroon.
authors.forename: Francois-Xavier
authors.initials: FX
authors.lastname: Mbopi-Keou
authors.affiliation: Université des Montagnes, Bangangté, Cameroon.
authors.forename: Isabelle Vanessa Monthe
authors.initials: IV
authors.lastname: Nkala
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon ; University Teaching Hospital, Yaoundé-Cameroon.
authors.forename: Ginette Claude Mireille
authors.initials: GC
authors.lastname: Kalla
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon.
authors.forename: Georges
authors.initials: G
authors.lastname: Nguefack-Tsague
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon ; University Teaching Hospital, Yaoundé-Cameroon.
authors.forename: Hortense Gonsu
authors.initials: HG
authors.lastname: Kamga
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon ; University of Dschang, Dschang, Cameroon.
authors.forename: Michel
authors.initials: M
authors.lastname: Noubom
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon.
authors.forename: Côme Ebana
authors.initials: CE
authors.lastname: Mvogo
authors.affiliation: Faculty of Medicine & Biomedical Sciences, University of Yaoundé I, Yaounde, Cameroon.
authors.forename: Maurice Aurelien
authors.initials: MA
authors.lastname: Sosso
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000453:epidemiology; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral / Q000097:blood; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use; D002163:Cameroon / Q000453:epidemiology; D060085:Coinfection; D015897:Comorbidity; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D015528:HIV Seroprevalence; D015497:HIV-1; D015498:HIV-2; D006509:Hepatitis B / Q000453:epidemiology*; D006510:Hepatitis B Antibodies; D006526:Hepatitis C / Q000453:epidemiology*; D006785:Hospitals, University / Q000706:statistics & numerical data; D006786:Hospitals, Urban / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D014505:Urban Population; D014611:Vaccination / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D000998:Antiviral Agents; D006510:Hepatitis B Antibodies
keywords: Bafoussam; Cameroon; HIV; Hepatitis B and C virus; associated factors; seroprevalence